ClinicalTrials.govpublic full text
A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab
asthma, severe eosinophilic asthma, anti-inflammatory, reduction period, inhaled corticosteroids, long-acting β2 agonist, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 882548
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.